Proposed amendments to the Poisons Standard - November 2020 ACMS/ACCS meetings

Overview

Scheduling amendments referred to expert advisory committee

This pre-meeting consultation is for applications and delegate initiated proposals to amend the scheduling in the Poisons Standard for certain substances. The scheduling amendments and any submissions received will be considered at either the meeting of the Advisory Committee on Medicines Scheduling (ACMS), the meeting of the Advisory Committee on Chemicals Scheduling (ACCS), or a joint meeting of these two committees in November 2020.

The proposals under consultation are detailed in the Public Notice of November 2020.

The due date for these consultations is close of business 28 September 2020.

Note: Any person may apply, or the Secretary of the Australian Department of Health or their delegate, may propose of their own initiative to amend the Poisons Standard. For more information about the Scheduling process or the legislative framework please refer to our website Scheduling of medicines and poisons.

Substances for which public comment is sought

• 1.1. amygdalin and hydrocyanic acid
• 1.2. cannabidiol
• 1.3. bilastine
• 1.4. budesonide + formoterol
• 1.5. psilocybin
• 1.6. N, α-Dimethyl-3,4-(methylenedioxy)phenylethylamine (MDMA)
• 2.1. azoxystrobin
• 2.2. triticonazole
• 3.1. azelaic acid
• 3.2. 2-hydroxyethyl methacrylate
• 3.3. magnesium hydroxide
• 3.4. tetrahydrofurfuryl alcohol (THFA)

What happens next

All public submissions will be published on the TGA website at Public submissions on scheduling matters, unless marked confidential or indicated otherwise in the submission information (see Privacy and your Personal information).

Following consideration of public submissions received before the closing date and advice from the expert advisory committee/s, decisions on the proposed amendments are anticipated to be published as interim decisions on the TGA website: Scheduling delegate's interim decisions & invitations for further comment  in  February 2021.